Enveric Biosciences Inc (ENVB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.78M
Last updated: Nov 17, 2026 at 11:03 AM ET
Enveric Biosciences Inc (ENVB) Earnings: Report Dates and Results
Enveric Biosciences (ENVB) is expected to report earnings on Mar 25, 2027. In the quarter ended Sep 30, 2026, Enveric Biosciences reported EPS of -$0.57. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
ENVB has an expected report date of Mar 25, 2027.
Earnings History
Of the 22 quarters below that had an estimate, ENVB beat 14 and missed 8. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 700.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.57 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2026 | N/A |
| Jun 30, 2026 | -$0.76 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2026 | N/A |
| Mar 31, 2026 | -$1.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2026 | N/A |
| Dec 31, 2025 | -$3.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 27, 2026 | N/A |
| Sep 30, 2025 | -$10.81 | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2025 | N/A |
| Jun 30, 2025 | -$11.65 | -$0.35 | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$4.82 | -$4.80 | N/A | -0.31% | Miss | N/A | N/A | N/A | May 14, 2025 | N/A |
| Dec 31, 2024 | -$2.03 | -$2.76 | N/A | +26.45% | Beat | N/A | N/A | 0 up, 0 down | Mar 31, 2025 | $340376 |
| Sep 30, 2024 | -$43.20 | -$93.60 | N/A | +53.85% | Beat | N/A | N/A | 0 up, 0 down | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$45.00 | -$99.00 | N/A | +54.55% | Beat | N/A | 1 | 0 up, 0 down | Aug 12, 2024 | N/A |
| Mar 31, 2024 | -$109.80 | -$139.50 | -$169.18 - -$109.79 | +21.29% | Beat | N/A | 2 | 0 up, 0 down | May 14, 2024 | N/A |
| Dec 31, 2023 | -$1.47 | -$1.54 | -$1.59 - -$1.50 | +4.55% | Beat | N/A | 2 | 0 up, 0 down | Mar 25, 2024 | $647092 |
| Sep 30, 2023 | -$287.12 | -$376.20 | -$404.96 - -$347.37 | +23.68% | Beat | N/A | 2 | 0 up, 0 down | Nov 13, 2023 | N/A |
| Jun 30, 2023 | -$450.42 | -$117.00 | N/A | -284.97% | Miss | N/A | N/A | N/A | Aug 14, 2023 | N/A |
| Mar 31, 2023 | -$4.24 | -$2.23 | N/A | -89.91% | Miss | N/A | N/A | 0 up, 0 down | May 15, 2023 | N/A |
| Dec 31, 2022 | -$344.11 | -$525.60 | N/A | +34.53% | Beat | N/A | N/A | 0 up, 0 down | Mar 31, 2023 | N/A |
| Sep 30, 2022 | -$582.21 | -$720.00 | -$809.92 - -$629.94 | +19.14% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$818.08 | -$675.00 | N/A | -21.20% | Miss | N/A | N/A | 0 up, 0 down | Aug 12, 2022 | N/A |
| Mar 31, 2022 | -$990.00 | -$1,080.00 | -$1,439.86 - -$719.93 | +8.33% | Beat | N/A | 2 | 0 up, 0 down | May 13, 2022 | N/A |
| Dec 31, 2021 | -$89.00 | -$8.00 | -$8.50 - -$7.50 | N/A | N/A | N/A | 2 | 0 up, 0 down | Mar 31, 2022 | N/A |
| Sep 30, 2021 | -$1,080.00 | -$1,260.00 | N/A | +14.29% | Beat | N/A | 2 | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$1,800.00 | -$1,575.00 | -$1,799.82 - -$1,349.87 | -14.29% | Miss | N/A | 2 | N/A | Aug 13, 2021 | N/A |
| Mar 31, 2021 | -$0.04 | -$9.50 | N/A | +99.58% | Beat | N/A | N/A | N/A | Apr 1, 2021 | N/A |
| Sep 30, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 16, 2020 | $8.48M |
| Jun 30, 2020 | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2020 | $8.25M |
| Mar 31, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2020 | $9.60M |
| Sep 30, 2019 | -$0.03 | -$5.00 | N/A | +99.50% | Beat | N/A | N/A | N/A | Nov 8, 2019 | $9.15M |
| Jun 30, 2019 | -$0.75 | -$150.00 | N/A | +99.50% | Beat | N/A | N/A | N/A | Aug 14, 2019 | $11.02M |
| Mar 31, 2019 | -$1.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2019 | $10.69M |
| Dec 31, 2018 | -$1,600.00 | -$200.00 | N/A | -700.00% | Miss | N/A | N/A | N/A | Mar 26, 2019 | $10.28M |
| Sep 30, 2018 | -$300.00 | -$250.00 | N/A | -20.00% | Miss | N/A | N/A | N/A | Nov 14, 2018 | $10.58M |
| Jun 30, 2018 | -$300.00 | -$400.00 | N/A | +25.00% | Beat | N/A | N/A | N/A | Aug 14, 2018 | $11.08M |
| Mar 31, 2018 | -$2.25 | -$2.00 | N/A | -12.50% | Miss | N/A | N/A | N/A | Apr 2, 2018 | $11.06M |
| Sep 30, 2017 | -$5.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2017 | $12.53M |
| Jun 30, 2017 | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2017 | $12.27M |
| Mar 31, 2017 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2017 | $12.34M |
| Dec 31, 2016 | $9.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2017 | $12.39M |
| Sep 30, 2016 | -$12.59 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2016 | $10.06M |
| Jun 30, 2016 | -$9.42 | N/A | N/A | N/A | N/A | -100.2% | N/A | N/A | Aug 12, 2016 | $6.69M |
| Mar 31, 2016 | -$87,941.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 16, 2016 | $7.01M |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$31.08, after -$200.03 the year before. It was -$210.15 for the year ended Dec 31, 2013, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$31.08 | N/A |
| Dec 31, 2024 | -$200.03 | N/A |
| Dec 31, 2023 | -$743.25 | N/A |
| Dec 31, 2022 | -$2,734.40 | N/A |
| Dec 31, 2021 | -$2,971.38 | N/A |
| Dec 31, 2018 | -$2,208.10 | N/A |
| Dec 31, 2016 | -$87,953.73 | N/A |
| Dec 31, 2015 | -$148,756.33 | N/A |
| Dec 31, 2014 | -$34,877.44 | N/A |
| Dec 31, 2013 | -$210.15 | N/A |
Frequently Asked Questions About ENVB
When is Enveric Biosciences's next earnings date?
Enveric Biosciences's next earnings report is expected for Mar 25, 2027.
How often does ENVB beat earnings estimates?
Enveric Biosciences beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of -12.62%.
ENVB pages: Overview, Earnings, Financials, Valuation, Competitors